Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy
14. November 2024 08:22 ET
|
Coloplast A/S
On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD)1 policy regarding skin substitute grafts/cellular and tissue-based...
Coloplast A/S - Indkaldelse til ordinær generalforsamling 2024
12. November 2024 06:01 ET
|
Coloplast A/S
Den ordinære generalforsamling i Coloplast A/S afholdestorsdag den 5. december 2024 kl. 15:30på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk, Danmark.Indkaldelsen...
Coloplast A/S - Notice of Annual General Meeting 2024
12. November 2024 06:01 ET
|
Coloplast A/S
The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium),...
Coloplast A/S - Årsrapport 2023/24 & Vederlagsrapport 2023/24
05. November 2024 01:28 ET
|
Coloplast A/S
Coloplast A/S - Årsrapport 2023/24 & Vederlagsrapport 2023/24 Organisk vækst på 8% og en overskudsgrad1 på 27% for regnskabsåret 2023/24. Den rapporterede omsætning målt...
Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24
05. November 2024 01:28 ET
|
Coloplast A/S
Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT margin1. Reported revenue in DKK grew 10% to DKK 27,030 million. Organic...
Coloplast A/S - Årsregnskabsmeddelelse 2023/24
05. November 2024 01:26 ET
|
Coloplast A/S
2023/24 Årsregnskabsmeddelelse 1. oktober 2023 – 30. september 2024 Coloplast leverede organisk vækst på 8% og en overskudsgrad1 på 26% i 4. kvartal, negativt påvirket af ekstraordinære...
Coloplast A/S - Full-Year Financial Results 2023/24
05. November 2024 01:26 ET
|
Coloplast A/S
2023/24 Announcement of full-year financial results 1 October 2023 - 30 September 2024 Coloplast delivered Q4 organic growth of 8% and an EBIT margin1 of 26%, which was negatively impacted by...
Coloplast A/S - Selskabsmeddelelse nr. 05/2024 - Coloplast udvider ledelsesteamet
05. November 2024 01:00 ET
|
Coloplast A/S
Coloplast udvider ledelsesteamet Coloplasts bestyrelse har i dag besluttet at udvide selskabets øverste ledelsesteam med omgående virkning. "Vi er trådt ind i det sidste år af vores...
Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team
05. November 2024 01:00 ET
|
Coloplast A/S
Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect. “We have...
Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET
21. Oktober 2024 09:09 ET
|
Coloplast A/S
Tuesday, 5 November 2024 at 11.00 – 12.00 CETIn connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the...